Cargando…

Metabolic Acidosis and Cardiovascular Disease in CKD

RATIONALE & OBJECTIVE: Metabolic acidosis related to chronic kidney disease (CKD) is associated with an accelerated decline in glomerular filtration rate (GFR) and the development of end-stage kidney disease. Whether metabolic acidosis is associated with cardiovascular (CV) events in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collister, David, Ferguson, Thomas W., Funk, Susan E., Reaven, Nancy L., Mathur, Vandana, Tangri, Navdeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551483/ https://www.ncbi.nlm.nih.gov/pubmed/34746740 http://dx.doi.org/10.1016/j.xkme.2021.04.011

Ejemplares similares

Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study
por: Reaven, Nancy L., et al.
Publicado: (2023)

Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study
por: Tangri, Navdeep, et al.
Publicado: (2021)

Association of metabolic acidosis with fractures, falls, protein-calorie malnutrition and failure to thrive in patients with chronic kidney disease
por: Mathur, Vandana, et al.
Publicado: (2022)

Metabolic Acidosis is Associated With Acute Kidney Injury in Patients With CKD
por: Zhu, Antonia, et al.
Publicado: (2022)

Effects of Veverimer in Older Adults With CKD and Metabolic Acidosis
por: Tangri, Navdeep, et al.
Publicado: (2021)

Physical Function in Adults With Metabolic Acidosis and Advanced CKD: Patient Reported Versus Assessed Physical Function
por: Tangri, Navdeep, et al.
Publicado: (2022)

Serum Bicarbonate and Graft and Patient Outcomes Among Kidney Transplant Recipients: A Retrospective Cohort Study Evaluating Changes in Serum Bicarbonate Over Time
por: Mathur, Vandana, et al.
Publicado: (2022)

Association of the Kidney Failure Risk Equation With High Health Care Costs
por: Reaven, Nancy L., et al.
Publicado: (2023)

Conventional Risk Factors Associated With Meaningful Outcomes in Advanced CKD
por: Collister, David, et al.
Publicado: (2018)

Association of serum bicarbonate with the development of kidney stones in patients with chronic kidney disease: a retrospective cohort study
por: Tangri, Navdeep, et al.
Publicado: (2023)

Metabolic acidosis in patients with kidney disease
por: Leon, Silvia J, et al.
Publicado: (2020)

Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial
por: Mathur, Vandana S., et al.
Publicado: (2022)

Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD
por: Li, Kevin, et al.
Publicado: (2020)

Patient Navigators for CKD and Kidney Failure: A Systematic Review
por: Taha, Ali, et al.
Publicado: (2022)

Association of Bone Mineral Density With Fractures Across the Spectrum of Chronic Kidney Disease: The Regina CKD-MBD Study
por: Prasad, Bhanu, et al.
Publicado: (2019)

Metabolic Acidosis in CKD: A Review of Recent Findings
por: Melamed, Michal L., et al.
Publicado: (2021)

Acute Kidney Injury in CKD: Role of Metabolic Acidosis
por: Kaufman, James S.
Publicado: (2022)

Development and External Validation of a Machine Learning Model for Progression of CKD
por: Ferguson, Thomas, et al.
Publicado: (2022)

A Cost-Minimization Analysis of Nurse-Led Virtual Case Management in Late-Stage CKD
por: Ferguson, Thomas W., et al.
Publicado: (2020)

An Economic Assessment Model of Rural and Remote Satellite Hemodialysis Units
por: Ferguson, Thomas W., et al.
Publicado: (2015)

Remote Dwelling Location Is a Risk Factor for CKD Among Indigenous Canadians
por: Harasemiw, Oksana, et al.
Publicado: (2018)

Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD
por: Tangri, Navdeep, et al.
Publicado: (2022)

Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study
por: Tangri, Navdeep, et al.
Publicado: (2023)

The Kidney Failure Risk Equation Score and CKD Care Delivery Measures: A Cross-sectional Study
por: Ahmed, Salman, et al.
Publicado: (2021)

Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial
por: Mathur, Vandana S, et al.
Publicado: (2021)

Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study
por: Kim, Hyo Jin, et al.
Publicado: (2019)

Safety and Efficacy of Veverimer in Acidotic Patients With CKD and Heart Failure
por: Mathur, Vandana, et al.
Publicado: (2021)

Prescription patterns of sodium and calcium polystyrene sulfonate in patients with hyperkalemia and chronic kidney disease receiving RAAS inhibitors
por: Ren, Hongru, et al.
Publicado: (2022)

Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study
por: Kushner, Pamela, et al.
Publicado: (2021)

Dietary potassium liberalization with fruit and vegetables versus potassium restriction in people with chronic kidney disease (DK-Lib CKD): a clinical trial protocol
por: Iman, Yasmin, et al.
Publicado: (2023)

The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD
por: Hundemer, Gregory L., et al.
Publicado: (2021)

Metabolic Acidosis Is an Independent Risk Factor of Renal Progression in Korean Chronic Kidney Disease Patients: The KNOW-CKD Study Results
por: Kim, Hyo Jin, et al.
Publicado: (2021)

Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study
por: Whitlock, Reid H., et al.
Publicado: (2023)

The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda
por: Fliser, Danilo, et al.
Publicado: (2011)

Association of frailty and physical function in patients with non-dialysis CKD: a systematic review
por: Walker, Simon R, et al.
Publicado: (2013)

4-Year Cost Trajectories in Real-World Patients Matched to the Metabolic Profiles of Trial Subjects Before/After Treatment with Phentermine-Topiramate
por: Li, James, et al.
Publicado: (2015)

Cardiovascular disease in older women with CKD
por: Radley, Alice, et al.
Publicado: (2023)

Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
por: Căpuşă, Cristina, et al.
Publicado: (2017)

Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study
por: Kuo, Chin-Chi, et al.
Publicado: (2015)

Initial and Recurrent Hyperkalemia Events in Patients With CKD in Older Adults: A Population-Based Cohort Study
por: Sriperumbuduri, Sriram, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hhtlvefgkkeunl0iat5up6shnp